1. Medtech Insight

Minute Insight: Virtuoso Surgical Unveiled Robotic System For Endoscopic Surgery

 
• By Marion Webb

Virtuoso Surgical said its newly unveiled robotic surgery system allows surgeons to use two hands to perform dexterous maneuvers within the body at the tip of the endoscope. US FDA submission is planned for 2024.

Minute Insight
• Source: Informa/Alamy

Virtuoso Surgical announced it will introduce its robotic system for endoscopic and endoluminal surgery, the Nashville-based surgical robotics start-up announced on 9 May.

“[The system gives] surgeons their hands back, equipping them to lift tissue, apply tension and maintain traction – in tight spaces within the body,” said Duke Herrell, CEO, chief medical...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.